Although numerous sequence variants in desmoglein-2 (DSG2) have been associated with arrhythmogenic right ventricular cardiomyopathy (ARVC), the functional impact of new sequence variations is difficult to estimate. This evidence concerns the gene DSG2 and arrhythmogenic right ventricular cardiomyopathy.